U54CA274329 (SINGH, PANKAJ KUMAR)Sep 20, 2022 - Aug 31, 2027 NIH Pancreatic Cancer ARTNet Center Role: Principal Investigator |
|
R01CA270234 (SINGH, PANKAJ KUMAR)Aug 1, 2022 - Jul 31, 2027 NIH Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer Role: Principal Investigator |
|
R01CA256911 (YANG, SHENGYU)Mar 1, 2022 - Feb 28, 2027 NIH Mitochondrial calcium signaling in pancreatic cancer metastasis and progression Role: Co-Principal Investigator |
|
R01CA216853 (SINGH, PANKAJ KUMAR)Mar 20, 2017 - Feb 28, 2022 NIH Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer Role: Principal Investigator |
|
R01CA210439 (SINGH, PANKAJ KUMAR)Dec 16, 2016 - Nov 30, 2021 NIH Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer Role: Principal Investigator |
|
R01CA163649 (SINGH, PANKAJ KUMAR)Sep 25, 2012 - Aug 31, 2024 NIH Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer Role: Principal Investigator |